Diseased Treated by Cord Blood Transplantation
In 1988, a 5-year-old French boy suffering from Fanconi's Anemia successfully received transplantation of his younger sister's cord blood, which was the first clinical application of cord blood and aroused worldwide enthusiasm about cord blood storage. At present, up to 112 clinical diseases1,2 including cancers, blood-related, immunity and metabolic disorders can be treated by cord blood.
At present, there are over 30,000 successful cord blood transplant cases over the world. Over 90 cord blood transplant cases were performed in Hong Kong, which included both children and adults.
Up to 112 diseases treated by cord blood transplantation
|Myelodysplastic Syndromes||5 Types|
|Other Disorders of Blood Cell Proliferation||55 Types|
|Inherited Disorder of Immune System||5 Types|
|Inherited Metabolic Diseases||30 Types|
|Other cancers||4 Types|
Umbilical cord stem cells used in medical treatments
Although the research in umbilical cord MSCs is still at an early stage, there are more than 300 clinical trials* underway using the same type of cell (primarily from bone marrow). Researchers believe that MSCs may help to treat various conditions such as diabetes, multiple sclerosis, heart failure, liver damage, and bone fractures.